Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Veracyte, Inc.    VCYT

VERACYTE, INC.

(VCYT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about VERACYTE, INC.
01/08VERACYTE : Announces Biopharmaceutical Collaboration with Acerta Pharma
BU
2019VERACYTE : Acquires Exclusive License to NanoString Diagnostics Platform, Positi..
BU
2019VERACYTE : Announces New Data That Advance Understanding of Genomic Alterations ..
BU
2019VERACYTE : Announces New Data Characterizing Genomic Alterations in Thyroid Canc..
BU
2019VERACYTE : 3Q Earnings Snapshot
AQ
2019VERACYTE : Announces Third Quarter 2019 Financial Results and Business Progress
BU
2019VERACYTE : Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab..
BU
2019VERACYTE : Announces Clinical Data Demonstrating Clinical Validity and Utility o..
BU
2019VERACYTE : Announces New Data Demonstrating That Envisia Genomic Classifier Impr..
BU
2019VERACYTE : to Release Third Quarter 2019 Financial Results and Business Progress..
BU
2019VERACYTE : to Announce New Clinical Data for First Noninvasive Nasal Swab Test t..
PU
2019VERACYTE : Announces Publication of Clinical and Analytical Validation Data for ..
BU
2019VERACYTE : Announces Publication of New Study Characterizing Gene Alterations in..
BU
2019VERACYTE : to Present at Upcoming Investor Conferences
BU
2019VERACYTE : 2Q Earnings Snapshot
AQ
More most relevant news
All news about VERACYTE, INC.
01/08VERACYTE : Announces Biopharmaceutical Collaboration with Acerta Pharma
BU
2019VERACYTE, INC. : Entry into a Material Definitive Agreement, Completion of Acqui..
AQ
2019VERACYTE : Acquires Exclusive License to NanoString Diagnostics Platform, Positi..
BU
2019VERACYTE : Announces New Data That Advance Understanding of Genomic Alterations ..
BU
2019VERACYTE : Announces New Data Characterizing Genomic Alterations in Thyroid Canc..
BU
2019VERACYTE : 3Q Earnings Snapshot
AQ
2019VERACYTE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
2019VERACYTE, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
2019VERACYTE : Announces Third Quarter 2019 Financial Results and Business Progress
BU
2019VERACYTE : Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab..
BU
More news
News in other languages on VERACYTE, INC.

- No features available -

Press releases
01/08VERACYTE : Announces Biopharmaceutical Collaboration with Acerta Pharma
BU
2019VERACYTE, INC. : Entry into a Material Definitive Agreement, Completion of Acqui..
AQ
2019VERACYTE : Acquires Exclusive License to NanoString Diagnostics Platform, Positi..
BU
2019VERACYTE : Announces New Data That Advance Understanding of Genomic Alterations ..
BU
2019VERACYTE : Announces New Data Characterizing Genomic Alterations in Thyroid Canc..
BU
More press releases
Sector news : Bio Diagnostics & Testing
06:25pU.S. Drugmakers Ship Therapies to China, Seeking to Treat Coronavirus
DJ
07:17aELI LILLY AND : Lilly, Incyte Say Baricitinib Meets Primary Endpoint in Phase 3 ..
DJ
07:12aAmerica's Gold Giant Bets on Dividends, Improved Mines to Hold Off Rival
DJ
01/22SIERRA ONCOLOGY : Shares Drop 12% Before Reverse Stock Split
DJ
01/22SIERRA ONCOLOGY : Declares 1-for-40 Reverse Stock Split
DJ
More sector news : Bio Diagnostics & Testing
Upcoming event on VERACYTE, INC.